← SynDRA
NAVOXIMOD
SynDRA canonical compound SYN0039175 — structure-anchored drug synonym record
Clinical phase
Phase 1
Primary target(s)
IDO1
Mechanism of action
indoleamine 2,3-dioxygenase inhibitor
Indication
melanoma
Disease area
oncology
All known targets
IDO1
Mechanisms of action (all sources)
indoleamine 2,3-dioxygenase inhibitor
Cross-references
PubChem CID:
66558287
ChEMBL:
CHEMBL3989951
DrugBank:
DB15439
PDB:
LKP
TTD: D06MHZ
Synonyms
GDC-0919
IDO-IN-7
NLG-919
NLG919
RG-6078
RG6078
RO-7077339
RO7077339
RO7077339-001
1-cyclohexyl-2-(5H-imidazo[5,1-a]isoindol-5-yl)ethanol
NLG 919
CHEMBL3629569
AK166956
1-Cyclohexyl-2-(5H-imidazo-[5,1-a]isoindol-5-yl)ethanol
alpha-Cyclohexyl-5H-imidazo[5,1-a]isoindole-5-ethanol
1-Cyclohexyl-2-(5H-imidazo[5,1-a]isoindol-5-yl)ethan-1-ol
YTRRAUACYORZLX-UHFFFAOYSA-N
GTPL9019
SCHEMBL13280897
GDC0919
EX-A574
DTXSID20735206
MolPort-035-395-785
HMS3653M05
AOB87373
GDC 0919
NLG919(GDC-0919)
2588AH
BDBM50126144
s7111
AKOS025287054
CS-3512
SB16495
ACN-028914
KS-0000062W
Look up NAVOXIMOD in the interactive SynDRA portal →